Vir Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Vir Biotechnology's estimated annual revenue is currently $284.4M per year.
- Vir Biotechnology received $66.0M in venture funding in August 2018.
- Vir Biotechnology's estimated revenue per employee is $473,211
- Vir Biotechnology's total funding is $793.6M.
- Vir Biotechnology's current valuation is $5.1B. (January 2022)
- Vir Biotechnology has 601 Employees.
- Vir Biotechnology grew their employee count by 40% last year.
Vir Biotechnology Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Vir Biotechnology?
Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.keywords:Biotechnology
Number of Employees
Employee Growth %
Vir Biotechnology News
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and...
Shares of Vir Biotechnology ( VIR -2.05% ) were up 20.5% so far for ... of an announcement on March 25 that drove Vir's stock price down.
Shares of Vir Biotechnology ( VIR -4.32% ) were skyrocketing 19.4% higher as of 12:33 p.m. ET on Wednesday. The big jump came after S&P...
GlaxoSmithKline and Vir Biotechnology, Inc. announced they have an agreement to enter a partnership to research and develop solutions for coronaviruses. And GSK will be investing $250 million in Vir. GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. announced they have signed a binding agre ...
Vir’s shares were up 11% on the Nasdaq in mid-day trading Thursday following the news. Biogen has been hit hard by an outbreak of the coronavirus following a management meeting in Boston two weeks ago. Shortly after the meeting, the company disclosed that three employees who attended had tested ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Vir Biotechnology Funding